Select Medical (NYSE:SEM) Announces Quarterly Earnings Results

Select Medical (NYSE:SEMGet Rating) announced its quarterly earnings results on Thursday. The health services provider reported $0.43 EPS for the quarter, missing the consensus estimate of $0.51 by ($0.08), Briefing.com reports. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Select Medical had a return on equity of 24.70% and a net margin of 5.45%. The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.22 EPS. Select Medical updated its FY 2022 guidance to EPS.

Select Medical Trading Up 4.1 %

Select Medical stock traded up $1.12 during midday trading on Friday, reaching $28.27. The stock had a trading volume of 1,525,366 shares, compared to its average volume of 816,151. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 2.73. Select Medical has a 52-week low of $21.40 and a 52-week high of $40.20. The firm has a market cap of $3.69 billion, a price-to-earnings ratio of 11.17, a price-to-earnings-growth ratio of 0.90 and a beta of 1.31. The company has a fifty day moving average of $25.64 and a 200 day moving average of $24.38.

Institutional Trading of Select Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SEM. BlackRock Inc. raised its position in Select Medical by 4.3% in the 1st quarter. BlackRock Inc. now owns 18,575,139 shares of the health services provider’s stock worth $445,617,000 after purchasing an additional 762,219 shares during the period. State Street Corp raised its position in Select Medical by 7.0% in the 1st quarter. State Street Corp now owns 4,079,467 shares of the health services provider’s stock worth $97,866,000 after purchasing an additional 266,914 shares during the period. Vanguard Group Inc. grew its stake in Select Medical by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 12,859,730 shares of the health services provider’s stock worth $308,505,000 after acquiring an additional 72,327 shares in the last quarter. Eaton Vance Management grew its stake in Select Medical by 1,888.9% in the 1st quarter. Eaton Vance Management now owns 58,852 shares of the health services provider’s stock worth $1,411,000 after acquiring an additional 55,893 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Select Medical by 4.1% in the 1st quarter. Invesco Ltd. now owns 938,154 shares of the health services provider’s stock worth $22,505,000 after acquiring an additional 36,875 shares in the last quarter. 90.98% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Credit Suisse Group decreased their target price on shares of Select Medical to $27.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 17th.

Select Medical Company Profile

(Get Rating)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

Featured Stories

Earnings History for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.